Näytetään tulokset 1 - 10 / 104
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi
 Julkaisujen tiedon ikoni

Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort:Data from the CERERRA Collaboration

Vertaisarvioitu
DOI
10.3899/jrheum.160460
Chatzidionysiou, Katerina; Lie, Elisabeth; Lukina, Galina; Hetland, Merete L.; Hauge, Ellen-Margreth...
Journal of rheumatology2017 Julkaisujen tiedon ikoni

Rituximab done:what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis

Vertaisarvioitu
Avoin saatavuus
DOI
10.1093/rheumatology/kev297
Walker, Ulrich A.; Jaeger, Veronika K.; Chatzidionysiou, Katerina; Hetland, Merete L.; Hauge, Ellen-...
Rheumatology2016 Julkaisujen tiedon ikoni

Transient Impact of Rituximab in H1N1 Vaccination-associated Narcolepsy With Severe Psychiatric Symptoms

Vertaisarvioitu
DOI
10.1097/NRL.0000000000000099
Sarkanen, Tomi; Alen, Reija; Partinen, Markku
Neurologist2016 Julkaisujen tiedon ikoni

Complete remission of central nervous system manifestations of IgG4-related disease with rituximab - a case report

Vertaisarvioitu
Avoin saatavuus
DOI
10.1177/17562864231186091
Sihvonen, Aleksi J.; Laakso, Sini M.; Tynninen, Olli; Saaren-Seppälä, Heikki; Löfberg, Mervi
Therapeutic advances in neurological disorders2023 Julkaisujen tiedon ikoni

PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report

DOI
10.1007/s00415-022-11539-4
Jussi Lehto; Marcus Sucksdorff; Marjo Nylund; Roope Raitanen; Markus Matilainen; Laura Airas
Journal of Neurology2023 Julkaisujen tiedon ikoni

Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma

Vertaisarvioitu
DOI
10.1182/blood-2016-03-704023
Albertsson-Lindblad, Alexandra; Kolstad, Arne; Laurell, Anna; Räty, Riikka; Gronbaek, Kirsten; Sundb...
Blood2016 Julkaisujen tiedon ikoni

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma:The ORCHARRD Study

Vertaisarvioitu
DOI
10.1200/JCO.2016.69.0198
van Imhoff, Gustaaf W.; McMillan, Andrew; Matasar, Matthew J.; Radford, John; Ardeshna, Kirit M.; Ku...
Journal of clinical oncology2017 Julkaisujen tiedon ikoni

Severe neutropenia after rituximab-treatment of multiple sclerosis

Rissanen E; Remes K; Airas L
Multiple Sclerosis And Related Disorders2018 Julkaisujen tiedon ikoni

Severe neutropenia after rituximab-treatment of multiple sclerosis

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.msard.2017.12.005
Eero Rissanen, Kari Remes, Laura Airas
Multiple Sclerosis and Related Disorders2018 Julkaisujen tiedon ikoni

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

Vertaisarvioitu
DOI
10.1182/blood-2018-10-879643
Swiss Grp Clinical Canc Res; Nordic Lymphoma Grp; Zucca, Emanuele; Rondeau, Stephanie; Vanazzi, Anna...
Blood2019

Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort:Data from the CERERRA Collaboration

Vertaisarvioitu
DOI
10.3899/jrheum.160460
2017

Rituximab done:what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis

Vertaisarvioitu
Avoin saatavuus
DOI
10.1093/rheumatology/kev297
2016

Transient Impact of Rituximab in H1N1 Vaccination-associated Narcolepsy With Severe Psychiatric Symptoms

Vertaisarvioitu
DOI
10.1097/NRL.0000000000000099
2016

Complete remission of central nervous system manifestations of IgG4-related disease with rituximab - a case report

Vertaisarvioitu
Avoin saatavuus
DOI
10.1177/17562864231186091
2023

PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report

DOI
10.1007/s00415-022-11539-4
2023

Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma

Vertaisarvioitu
DOI
10.1182/blood-2016-03-704023
2016

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma:The ORCHARRD Study

Vertaisarvioitu
DOI
10.1200/JCO.2016.69.0198
2017

Severe neutropenia after rituximab-treatment of multiple sclerosis

2018

Severe neutropenia after rituximab-treatment of multiple sclerosis

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.msard.2017.12.005
2018

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

Vertaisarvioitu
DOI
10.1182/blood-2018-10-879643
2019